Rofecoxib Efficacy and Safety Evaluation Trial in Hemophilic Arthropathy

Condition:   Hemophilic Arthropathy Interventions:   Drug: TRM-201 (Rofecoxib);   Drug: Placebo Sponsor:   Tremeau Pharmceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials